Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Light

Showing results (61-70 of 418) with videos related to

Pageof 42
Sort By:
Biological Psychiatry|March 8, 2000
Do self-reports of perceptual anomalies reflect gating deficits in schizophrenia patients?G A Light, D L Braff
Frontiers in Psychiatry|December 5, 2018
Using EEG-Guided Basket and Umbrella Trials in Psychiatry: A Precision Medicine Approach for Cognitive Impairment in SchizophreniaYash B Joshi, Gregory A Light
The American Journal of Psychiatry|December 1, 2001
Measuring P50 suppression and prepulse inhibition in a single recording sessionG A Light, D L Braff
Current Psychiatry Reports|December 21, 2000
Human and animal studies of schizophrenia-related gating deficitsG A Light, D L Braff
The Biochemical Journal|August 1, 1971
A comparison of mitochondria from Torulopsis utilis grown in continuous culture with glycerol, iron, ammonium, magnesium or phosphate as the growth-limiting nutrientP A Light, P B Garland
Current Topics in Behavioral Neurosciences|May 23, 2014
Neurophysiological biomarkers informing the clinical neuroscience of schizophrenia: mismatch negativity and prepulse inhibition of startleGregory A Light, Neal R Swerdlow
Journal of Social Work in End-Of-Life & Palliative Care|June 18, 2023
Pathways of Individuals Experiencing Serious Illness While Homeless: An Exploratory 4-Point Typology from the RASCAL-UP StudyIan M Johnson, Michael A Light
The American Journal of Psychiatry|April 1, 2024
Predicting Conversion to Psychosis: What Lies Beyond the Biomarkers?Gregory A Light, Neal R Swerdlow
Cancer Letters|August 1, 1985
Alterations in concentrations of cyclic guanosine 3',5'-monophosphate in guinea pig urine during the development of a transplantable leukaemiaA C Williams, P A Light
Psychopharmacology|May 1, 2004
Preattentional and attentional cognitive deficits as targets for treating schizophreniaDavid L Braff, Gregory A Light
Pageof 42

Showing results (61-70 of 418) with videos related to

Sort By:
Pageof 42
Biological Psychiatry|March 8, 2000
Do self-reports of perceptual anomalies reflect gating deficits in schizophrenia patients?G A Light, D L Braff
Frontiers in Psychiatry|December 5, 2018
Using EEG-Guided Basket and Umbrella Trials in Psychiatry: A Precision Medicine Approach for Cognitive Impairment in SchizophreniaYash B Joshi, Gregory A Light
The American Journal of Psychiatry|December 1, 2001
Measuring P50 suppression and prepulse inhibition in a single recording sessionG A Light, D L Braff
Current Psychiatry Reports|December 21, 2000
Human and animal studies of schizophrenia-related gating deficitsG A Light, D L Braff
The Biochemical Journal|August 1, 1971
A comparison of mitochondria from Torulopsis utilis grown in continuous culture with glycerol, iron, ammonium, magnesium or phosphate as the growth-limiting nutrientP A Light, P B Garland
Current Topics in Behavioral Neurosciences|May 23, 2014
Neurophysiological biomarkers informing the clinical neuroscience of schizophrenia: mismatch negativity and prepulse inhibition of startleGregory A Light, Neal R Swerdlow
Journal of Social Work in End-Of-Life & Palliative Care|June 18, 2023
Pathways of Individuals Experiencing Serious Illness While Homeless: An Exploratory 4-Point Typology from the RASCAL-UP StudyIan M Johnson, Michael A Light
The American Journal of Psychiatry|April 1, 2024
Predicting Conversion to Psychosis: What Lies Beyond the Biomarkers?Gregory A Light, Neal R Swerdlow
Cancer Letters|August 1, 1985
Alterations in concentrations of cyclic guanosine 3',5'-monophosphate in guinea pig urine during the development of a transplantable leukaemiaA C Williams, P A Light
Psychopharmacology|May 1, 2004
Preattentional and attentional cognitive deficits as targets for treating schizophreniaDavid L Braff, Gregory A Light
Pageof 42